ITRM20060367A1 - HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS - Google Patents

HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS

Info

Publication number
ITRM20060367A1
ITRM20060367A1 ITRM20060367A ITRM20060367A1 IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1 IT RM20060367 A ITRM20060367 A IT RM20060367A IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1
Authority
IT
Italy
Prior art keywords
hngf
pharmaceutical compositions
therapeutic uses
mutein therapeutic
mutein
Prior art date
Application number
Other languages
Italian (it)
Inventor
Simona Capsoni
Antonino Cattaneo
Sonia Covaceuszach
Original Assignee
Lay Line Genomics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lay Line Genomics Spa filed Critical Lay Line Genomics Spa
Priority to ITRM20060367 priority Critical patent/ITRM20060367A1/en
Priority to PCT/EP2007/057215 priority patent/WO2008006893A1/en
Publication of ITRM20060367A1 publication Critical patent/ITRM20060367A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITRM20060367 2006-07-13 2006-07-13 HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS ITRM20060367A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (en) 2006-07-13 2006-07-13 HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS
PCT/EP2007/057215 WO2008006893A1 (en) 2006-07-13 2007-07-12 Muteins of hngf, therapeutic uses and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (en) 2006-07-13 2006-07-13 HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
ITRM20060367A1 true ITRM20060367A1 (en) 2008-01-14

Family

ID=38508826

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM20060367 ITRM20060367A1 (en) 2006-07-13 2006-07-13 HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS

Country Status (2)

Country Link
IT (1) ITRM20060367A1 (en)
WO (1) WO2008006893A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20161364A1 (en) * 2016-03-04 2017-09-04 Antonino Cattaneo TNF ALPHA ASTROCITARY INHIBITOR FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES.
US11883464B2 (en) * 2016-03-18 2024-01-30 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Nerve growth factor fusion protein, preparation method and use thereof
AR114110A1 (en) 2018-02-28 2020-07-22 Lilly Co Eli ANTI-TRKA ANTIBODY
WO2019207106A1 (en) 2018-04-27 2019-10-31 Chiesi Farmaceutici Spa Production of nerve growth factor (ngf) and of muteins thereof
MX2021002983A (en) * 2018-09-17 2021-05-14 Chiesi Farm Spa Agent for treatment of dermatological disorders.
EP4031117B1 (en) 2019-09-17 2024-07-24 Chiesi Farmaceutici S.p.A. Ngf mutant for use in treatment or prevention of ophthalmic disorders
WO2022026468A1 (en) * 2020-07-27 2022-02-03 Human Cell Co. Ngf variants, production, compositions, and therapeutic uses
EP4039269A1 (en) * 2021-02-05 2022-08-10 Dompe' Farmaceutici S.P.A. Ngf isoform for use in the treatment of ocular pathologies
US20240165203A1 (en) 2021-03-25 2024-05-23 Chiesi Farmaceutici S.P.A. Combined treatment of brain injury
WO2024140625A1 (en) * 2022-12-28 2024-07-04 舒泰神（北京）生物制药股份有限公司 Method for screening and/or identifying mutable site in ngf, and method for screening and/or identifying ngf mutant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365373B2 (en) * 1997-04-25 2002-04-02 Genentech, Inc. Nucleic acids encoding NGF variants
CA2286558A1 (en) * 1997-04-25 1998-11-05 Genentech, Inc. Ngf variants
WO2005040335A2 (en) * 2003-10-23 2005-05-06 Monika Holmberg A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto

Also Published As

Publication number Publication date
WO2008006893A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
ITRM20060367A1 (en) HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS
CY2014030I1 (en) THERAPEUTIC COMPOSITIONS INCLUDING INGENOL-3-ANGELATE
BRPI0813955A2 (en) therapeutic compositions and their use
BRPI0923283A2 (en) therapeutic peptide conjugates and uses thereof
DK2185164T3 (en) COMPOSITION AND THERAPEUTIC ANTITUMORVACCINE
NO20075628L (en) Pharmaceutical formulations
DK1959991T3 (en) THERAPEUTIC VACCINE
BRPI0820381A2 (en) Pharmaceutical Formulations
DK2073795T3 (en) Abuse-safe drug formulation
BRPI0511900A (en) pharmaceutical compositions
BRPI1009324A2 (en) and / or pharmaceutically acceptable compounds thereof, pharmaceutical composition and their uses
RU2398586C3 (en) PHARMACEUTICAL COMPOSITION
ATE542815T1 (en) COCRYSTALS AND PHARMACEUTICAL COMPOSITIONS THEREOF
BRPI0715712A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0813000A2 (en) THERAPEUTIC COMPOSITIONS AND USE OF THEM
BRPI0807544A2 (en) PHARMACEUTICAL SOLID AND VACCINE DOSE
BRPI0719393A2 (en) Pharmaceutical Composition
CR10619A (en) PEPTIDE MIMETICBODIES-1 SIMILAR TO HUMAN GLUCAGON, COMPOSITIONS, METHODS AND USES
ATE493119T1 (en) PHARMACEUTICAL COMPOSITION
DK2035369T3 (en) THERAPEUTIC
BRPI0720234A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0716445A2 (en) pharmaceutical composition
ATE420081T1 (en) TRIFLUORMETHYLBENZAMIDE DERIVATIVES AND THERAPEUTIC USES THEREOF
BRPI0907228A2 (en) Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
ATE530546T1 (en) COCRYSTALS AND PHARMACEUTICAL COMPOSITIONS THEREOF